Tag: clinical study

Positive Safety Results Reported for Viaskin Peanut Phase III Trial

The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.

Study: Nine Children Suffer Severe Symptoms in OIT Trial

The survey was initiated after a report that a child suffered cardio-respiratory arrest during OIT.

Genome Study Provides More Clarity on Genetic Causes of Food Allergy

Study provides more clues in the race to understand the causes and develop treatments for food allergies.

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

More exciting news as pharma companies work to extend the effectiveness of their therapies in combination.

BAT II Study to Determine Effectiveness of ‘Food Challenge in a...

The study will compare the accuracy of the Basophil Activation Test to the gold standard.

DBV Completes Phase III Study of Peanut Patch

The phase III trial was designed to assess the safety and routine clinical use of Viaskin Peanut.

Study: Immune and Nervous Systems Communicate in the Gut

Link provides another clue into the mechanisms of chronic inflammatory diseases like food allergies and asthma.

Th2A: the Key to Unlocking Better Testing and a Cure for...

A look at what all the excitement is about.

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.

Connect with Us

29,672FansLike
89FollowersFollow
4,390FollowersFollow
33SubscribersSubscribe